
In a zzso zzso study the authors evaluated the efficacy and safety of zzso zzso in pediatric cancer patients receiving zzso or zzso zzso zzso patients with solid tumors received zzso zzso 3 times weekly at a dose of 150 zzso zzso zzso zzso or zzso 12 zzso and zzso or zzso 16 zzso or 300 zzso zzso zzso 12 zzso for 28 zzso Data from treated patients were compared to data from 37 zzso control zzso zzso zzso differences in favor of the zzso zzso Patients were observed in overall red blood cell zzso requirements zzso zzso zzso and overall zzso zzso requirements zzso zzso zzso Additionally, significant zzso differences favoring zzso zzso were seen by zzso zzso zzso mean time to first red blood cell zzso zzso zzso zzso Mean zzso zzso was maintained at baseline levels in the zzso zzso group for most of the course of the zzso No drug-related adverse events were seen in zzso zzso zzso 

